← Leaderboards
Amy F Pruitt
University Of Pennsylvania
$273,406
Attributed
$273,406
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$273,406 · 1
By mechanism
M01$273,406 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Amos B Smith$26,356,961
- David W Christianson$17,751,022
- Ian Frank$25,757,892
- Rob R Macgregor$4,980,820
- Ravi K Amaravadi$13,477,656
Others in their field
Top investigators on “Antineoplastics”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,744,647
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Charles A Coltman · Southwest Oncology Group$134,454,243
- Gregory H Reaman · National Childhood Cancer Foundation$112,139,479
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Richard L Schilsky · University Of Chicago$90,728,118
Research focus
AntineoplasticsClinical ResearchDrug Screening /EvaluationEnzyme InhibitorsGlioblastoma MultiformeHuman SubjectHuman Therapy EvaluationHydroxamateMetalloendopeptidasesNeoplasm /Cancer ChemotherapySarcoma
Grant awards (6)
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OR GLIOSARCOMA$124,146
M01 · FY2002 · RR
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OR GLIOSARCOMA$124,146
M01 · FY2001 · RR
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OR GLIOSARCOMA$0
M01 · FY2001 · RR
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OR GLIOSARCOMA$25,114
M01 · FY2000 · RR
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OR GLIOSARCOMA$0
M01 · FY2000 · RR
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OR GLIOSARCOMA$0
M01 · FY2000 · RR